Globe Life Inc. (NYSE:GL) Given Average Rating of “Moderate Buy” by Analysts

Shares of Globe Life Inc. (NYSE:GL) have been given an average recommendation of “Moderate Buy” by the eleven research firms that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $172.00.

Several research firms recently commented on GL. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 13th. Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and issued a $168.00 price target on shares of Globe Life in a report on Thursday, March 26th. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Wells Fargo & Company raised their price objective on Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 25th. Finally, Texas Capital raised Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th.

Globe Life Price Performance

Shares of Globe Life stock opened at $136.55 on Thursday. Globe Life has a 52 week low of $109.38 and a 52 week high of $152.71. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. The stock has a market cap of $10.71 billion, a PE ratio of 9.70 and a beta of 0.46. The company’s 50-day moving average price is $141.40 and its two-hundred day moving average price is $138.80.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter last year, the business posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, sell-side analysts anticipate that Globe Life will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be issued a dividend of $0.33 per share. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life’s dividend payout ratio (DPR) is currently 7.67%.

Insiders Place Their Bets

In related news, CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total value of $1,431,400.00. Following the transaction, the chief marketing officer owned 17,479 shares of the company’s stock, valued at approximately $2,501,944.06. This trade represents a 36.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO James Matthew Darden sold 18,318 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total value of $2,657,941.80. Following the sale, the chief executive officer owned 51,093 shares in the company, valued at approximately $7,413,594.30. The trade was a 26.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 82,807 shares of company stock worth $12,041,286 over the last three months. Company insiders own 2.11% of the company’s stock.

Institutional Investors Weigh In On Globe Life

Several hedge funds have recently made changes to their positions in GL. Mather Group LLC. acquired a new position in Globe Life in the 3rd quarter worth approximately $28,000. CYBER HORNET ETFs LLC purchased a new position in Globe Life during the 2nd quarter worth approximately $28,000. Hilton Head Capital Partners LLC acquired a new stake in Globe Life during the 4th quarter valued at $30,000. MUFG Securities EMEA plc acquired a new stake in Globe Life during the 2nd quarter valued at $31,000. Finally, Quent Capital LLC purchased a new stake in shares of Globe Life in the third quarter valued at $36,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.